Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104743) titled 'Study to evaluate whether adding dapagliflozin to existing blood pressure treatment improves blood pressure control in patients with uncontrolled hypertension' on Feb. 25.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Permuted block randomization, fixed Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Open Label

Primary Sponsor: Indira Gandhi Medical College, Shimla

Condition: Health Condition 1: I10- Essential (primary) hypertension

Intervention: Intervent...